ArticleFrontiers in public health2026
Longitudinal trajectories of total, cognitive-affective, and somatic depressive symptoms in relation to hip fracture risk: evidence from the HRS and ELSA cohorts.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Prior research has established a link between depressive symptoms and the incidence of hip fractures, with most studies relying on a single assessment and failing to differentiate among symptom subtypes. This study utilized repeated measurements to construct symptom trajectories and separately examined the cognitive-emotional and physical dimensions to elucidate their relationship with the risk of hip fractures. Methods: We analyzed data from individuals aged 45 and older participating in the Health and Retirement Study (HRS, USA) and the English Longitudinal Study of Ageing (ELSA, UK), excluding those with a history of hip fractures. Depressive symptoms were assessed biennially using the Center for Epidemiological Studies Depression Scale (CES-D) over a span of eight consecutive years. Participants were categorized into five trajectory groups based on their CES-D scores: consistently low, decreasing, fluctuating, increasing, and consistently high. Over the subsequent 10 years, the incidence of hip fractures was ascertained through self-reported physician diagnoses. The Cox proportional hazards model was employed to calculate the hazard ratio (HR) and 95% confidence interval (CI) to examine the association between the trajectory of depressive symptoms and the risk of hip fractures, while controlling for sociodemographic factors, health behaviors, and overall health status. Results: Among 7,014 participants (mean age 64.4 years, 61.2% female), 382 incident hip fractures occurred during follow-up. In the fully adjusted model, participants with increasing total depressive symptoms (HR = 1.53, 95% CI: 1.12-2.09) and consistently high total depressive symptoms (HR = 1.70, 95% CI: 1.12-2.56) had elevated hip fracture risk compared with those with consistently low symptoms. Decreasing (HR = 0.81, 95% CI: 0.53-1.22) and fluctuating trajectories (HR = 1.13, 95% CI: 0.85-1.51) were not significantly associated with hip fracture risk. Regarding symptom subtypes, consistently high cognitive-affective symptoms were associated with increased hip fracture risk (HR = 1.71, 95% CI: 1.09-2.69). For somatic symptoms, both increasing (HR = 1.61, 95% CI: 1.17-2.20) and consistently high trajectories (HR = 1.72, 95% CI: 1.06-2.81) were associated with increased hip fracture risk. Conclusion: Elevated hip fracture risk is linked to increasing and consistently high total depressive symptom trajectories, whereas decreasing and fluctuating patterns do not significantly differ from consistently low levels. Greater fracture risk is indicated by consistently high cognitive-affective symptoms and both increasing and consistently high somatic symptoms. These findings imply that monitoring depressive symptom trajectories and their subtypes may help identify individuals at elevated fracture risk and inform targeted prevention strategies. Additional research on underlying mechanisms and approaches to identify and address high-risk populations is necessary.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.